Novo Nordisk

Organization

Danish pharmaceutical company and manufacturer of Ozempic and Wegovy

15 stories

Study Finds GLP-1 Weight-Loss Drugs May Cause Less Muscle Loss Than Previously Believed

GLP-1 Drug Users Report Emotional Blunting, Raising 'Ozempic Personality' Concerns

GLP-1 Drugs Show Health Benefits for Patients Who Do Not Lose Weight

Scientists Identify Biological Mechanism Behind Why Ozempic Fails for Some Patients

Study Links GLP-1 Drug Side Effects to Individual Genetic Variations

AI Analysis of 400,000 Reddit Posts Identifies Previously Overlooked GLP-1 Drug Side Effects

politics47d ago

Trump Imposes Up to 100% Tariff on Brand-Name Drug Imports

FDA Approves Eli Lilly's Oral Weight-Loss Drug, Entering Market Against Novo Nordisk

FDA Approves Higher-Dose Wegovy for Weight Loss Treatment

Eli Lilly's Obesity Drug Retatrutide Succeeds in Late-Stage Diabetes Trial

Jensen Huang Envisions AI Transforming Biology Into Engineering Discipline

Wegovy Users Face Five Times Greater Risk of Sudden Sight Loss Than Ozempic Users

Two Deaths Reported to Regulators Potentially Linked to Weight-Loss Injections

business72d ago

Hims & Hers Stock Surges Amid Weight-Loss Drug Battle with Novo Nordisk

GLP-1 Weight-Loss Drugs Linked to Bone and Tendon Injuries